VPAResearch: Market Research Reports

Publications found: 64,029

Sort by:

ZigBee Home Automation Market Outlook- Global Industry Size, Share, Trends, Growth Opportunities, Forecasts by Types, Applications, Countries, and Companies, 2023 to 2030

US$ 2,880.00

Future of ZigBee Home Automation Market Size, 2023- Trends, Outlook and Growth Opportunities, Market Share, Global Industry Analysis, Insights, Competition, and Forecasts to 2030 The ZigBee Home Autom...

May 2023 170 pages

Achondroplasia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Achondroplasia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Achondroplasia pipeline...

February 2023 60 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 &nbs...

February 2023 110 pages

Acromegaly Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Acromegaly Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Acromegaly pipeline candidat...

February 2023 100 pages

Actinic (Solar) Keratosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Actinic (Solar) Keratosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Actinic (Sola...

February 2023 90 pages

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For ea...

February 2023 80 pages

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1&n...

February 2023 70 pages

African Trypanosomiasis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

African Trypanosomiasis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the African Trypano...

February 2023 50 pages

Alcoholic Hepatitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Alcoholic Hepatitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Alcoholic Hepatitis...

February 2023 60 pages

Allergic Conjunctivitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Allergic Conjunctivitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Allergic Conjun...

February 2023 120 pages

Alpha-1 Antitrypsin Deficiency (A1AD) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Alpha-1 Antitrypsin Deficiency (A1AD) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the A...

February 2023 170 pages

Amyloidosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Amyloidosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Amyloidosis pipeline candid...

February 2023 190 pages

Anaphylaxis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Anaphylaxis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Anaphylaxis pipeline candid...

February 2023 60 pages

Anaplastic Astrocytoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Anaplastic Astrocytoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Anaplastic Astro...

February 2023 170 pages

Anaplastic Oligoastrocytoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Anaplastic Oligoastrocytoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Anaplastic...

February 2023 40 pages

Anemia in Chronic Kidney Disease (Renal Anemia) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Anemia in Chronic Kidney Disease (Renal Anemia) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For eac...

February 2023 150 pages

Anesthetic Effect Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Anesthetic Effect Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Anesthetic Effect pip...

February 2023 120 pages

Angina (Angina Pectoris) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Angina (Angina Pectoris) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Angina (Angina...

February 2023 90 pages

Anthrax Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Anthrax Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Anthrax pipeline candidate, det...

February 2023 110 pages

Aplastic Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Aplastic Anemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Aplastic Anemia pipelin...

February 2023 80 pages

Arrhythmias Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Arrhythmias Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Arrhythmias pipeline candid...

February 2023 80 pages

Arterial Thrombosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Arterial Thrombosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Arterial Thrombosis...

February 2023 40 pages

Aspergillosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Aspergillosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Aspergillosis pipeline ca...

February 2023 140 pages

Atrial Fibrillation Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Atrial Fibrillation Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Atrial Fibrillation...

February 2023 140 pages

Atypical Hemolytic Uremic Syndrome (Nondiarrhea – Associated Hemolytic Uremic Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Atypical Hemolytic Uremic Syndrome (Nondiarrhea – Associated Hemolytic Uremic Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under devel...

February 2023 60 pages

Autism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Autism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Autism pipeline candidate, detai...

February 2023 180 pages

Axillary Hyperhidrosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Axillary Hyperhidrosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Axillary Hyperhi...

February 2023 40 pages

B-Cell Chronic Lymphocytic Leukemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

B-Cell Chronic Lymphocytic Leukemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the B-C...

February 2023 110 pages

Bacterial Conjunctivitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Bacterial Conjunctivitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Bacterial Conj...

February 2023 40 pages

Bacterial Vaginosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Bacterial Vaginosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Bacterial Vaginosis...

February 2023 100 pages

Basal Cell Carcinoma (Basal Cell Epithelioma) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Basal Cell Carcinoma (Basal Cell Epithelioma) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each...

February 2023 190 pages

Batten Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Batten Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Batten Disease pipeline...

February 2023 90 pages

Becker Muscular Dystrophy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Becker Muscular Dystrophy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Becker Muscul...

February 2023 50 pages

Behcet Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Behcet Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Behcet Disease pipeline...

February 2023 40 pages

Benign Prostatic Hyperplasia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Benign Prostatic Hyperplasia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Benign Pro...

February 2023 100 pages

Binge Eating Disorder Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Binge Eating Disorder Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Binge Eating Diso...

February 2023 60 pages

Birch Pollen Allergy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Birch Pollen Allergy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Birch Pollen Aller...

February 2023 40 pages

Blepharitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Blepharitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Blepharitis pipeline candid...

February 2023 70 pages

Bone Metastasis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Bone Metastasis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Bone Metastasis pipelin...

February 2023 140 pages

Botulism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Botulism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Botulism pipeline candidate, d...

February 2023 40 pages

Bronchiectasis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Bronchiectasis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Bronchiectasis pipeline...

February 2023 130 pages

Bronchopulmonary Dysplasia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Bronchopulmonary Dysplasia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Bronchopulmo...

February 2023 80 pages

Bullous Pemphigoid Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Bullous Pemphigoid Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Bullous Pemphigoid p...

February 2023 70 pages

Burkholderia Pseudomallei Infections (Melioidosis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Burkholderia Pseudomallei Infections (Melioidosis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For...

February 2023 40 pages

Burns Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Burns Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Burns pipeline candidate, details...

February 2023 190 pages

Canavan Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Canavan Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Canavan Disease pipelin...

February 2023 40 pages

Cancer Anorexia-Cachexia Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Cancer Anorexia-Cachexia Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Cance...

February 2023 130 pages

Cancer Pain Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Cancer Pain Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Cancer Pain pipeline candid...

February 2023 190 pages

Candidiasis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Candidiasis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Candidiasis pipeline candid...

February 2023 190 pages

Cat Allergy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Cat Allergy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Cat Allergy pipeline candid...

February 2023 40 pages

Filters

Clear all